Completed Cancer Lungs & Breathing

RADIANT: Regulatory Science Empowering Innovation in Transformative Digital Health and AI.

In plain English

AI plain-English summary

The UK is building a global network of experts to rewrite the rules for digital health and AI products—from smartphone apps that diagnose illness to software that powers medical devices. This matters because the current regulatory system was not designed for technologies that evolve faster than the rules meant to govern them. Without a supportive framework, innovative products can be delayed or blocked, while unsafe ones can slip through. RADIANT aims to close this gap by making regulation more proportionate, evidence-based, and business-friendly, without compromising safety or inclusivity. If successful, this network could reshape how digital health and AI products are approved and monitored. The global market for these technologies is projected to reach $188 billion by 2030, and the UK is already a pioneer in the sector. Better regulation could accelerate the rollout of safe, effective diagnostics, predictive tools, and treatment devices—improving healthcare infrastructure and patient outcomes without requiring people to think about the rules that made it possible.

View original technical description
Regulation is crucial to the safety and effectiveness of digital health and Al products. These include diagnostics, devices which predict and treat ill-health, software which makes physical devices work, and smartphone apps. Increasingly, healthcare products using artificial intelligence (Al). The UK is a global pioneer in this sector, worth $188Bn globally by 2030. Given its strategic importance and rapid technological innovation, there is increasing need for a supportive regulatory environment that encourages innovation whilst ensuring safety. RADIANT's vision is to be an international network of expertise in regulatory science and innovation, empowering transformative digital health and healthcare Al. RADIANT will unleash digital health and Al innovation by making regulation more proportionate, well-evidenced, business-friendly and user­focused, whilst ensuring products are safe, secure, inclusive, trusted and sustainable.

View the original record at the funder ↗

Researchers

Gabriella Spinelli (Principal Investigator)

Related Research

Grants with similar aims, by meaning.

RADIANT: Regulatory Science Empowering Innovation in Transformative Medical Software and AI.
Centre of Excellence for Regulatory Science and Innovation in AI & Digital Health Technologies (CERSI-AI)
UK Regulatory Science and Innovation Network in AI & Digital Health Technologies
CERSI for the Digital Transformation of Medicines Development and Manufacturing
The AMRI (Accelerating Medical Technology Regulatory Science Innovation) Network

Original classification

Partnership and Contribution

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.